THE-PENINSULA-HOTELS
9.2.2021 07:02:26 CET | Business Wire | Press release
The Peninsula Hotels, whose international hospitality brand has epitomised glamour and luxury for nearly a century, today announced the winner of its sixth annual classic car showcase, The Peninsula Classics 2020 Best of the Best Award. The winning car, the 1954 Ferrari 750 Monza, coachwork by Scaglietti , has achieved distinction both for its impressive racing history and its exacting restoration. It became eligible as a Best of the Best Award contender after winning Best of Show at the 2020 Palm Beach Cavallino Classic.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210208005295/en/
The Best of the Best Award was co-founded in 2015 by The Hon. Sir Michael Kadoorie, Chairman of The Hongkong and Shanghai Hotels, Limited (owner and operator of The Peninsula Hotels), along with William E. (Chip) Connor, Bruce Meyer and Christian Philippsen. The Award celebrates the fine engineering and design of classic cars built by internationally renowned manufacturers, selected from an exceptional short list of winners from the most exclusive concours. This year’s award has a contracted list of nominees due to cancellation or postponement of partner concours in 2020 as a result of the COVID-19.
The 1954 Ferrari 750 Monza was chosen from a selection of four nominees crafted by automakers from Italy, Germany, and the United States, including a 1969 Porsche 917 KH Coupé, coachwork by the Factory, 2020 Best of Show, Concours of Elegance Hampton Court Palace, 1931 Alfa Romeo 8C 2300 Monza Spider, coachwork by Zagato, 2020 Best of Show, Salon Privé and a 1929 Duesenberg Model J Town Limousine, coachwork by Murphy, 2020 Best of Show, Amelia Island Concours d’Elegance.
The winner was selected by The Best of the Best Award’s esteemed panel of judges, including, amongst others, designers Gordon Murray (former Formula 1 designer for Brabham and McLaren) and Anne Asensio (Vice President of Design Experience at Dassault Systèmes), and prominent classic car collectors Laurence Graff and Jay Leno.
“It was a difficult task for our judges to select a winner this year. Our judging procedures had to be carried out remotely and unfortunately the main awards event had to be cancelled, with social distancing measures and safety our top priority,” said The Hon. Sir Michael Kadoorie. “With such a prestigious collection of nominees, choosing one winner was especially challenging. However, it is always a great pleasure to spotlight the remarkable achievements of the automotive industry, and to create a small spark of joy in the current challenging times. These classic vehicles are an enduring testament to human artistry and ingenuity.”
The winning 750 Monza made its original debut with a 2-litre motor at the Inaugural Grand Prix of the Imola Autodrome in June of 1954. After driver Umberto Maglioli secured first place for Scuderia Ferrari with the car, it was subsequently fitted with a 3-litre engine and went on to compete in several other major races that year, including the Monsanto Grand Prix (where it won), and Nassau Race Week – where it was driven by its original owner, Alfonso de Portago, and secured a 1st and two 2nd places.
The car’s next owner, Sterling Edwards, raced the 750 Monza over the next two years mainly in California, including the Pebble Beach Road Races (an event he founded) in 1955 and 1956 – garnering four 1st-place and two first-in-class wins in the car. After the tragic death of his friend Ernie McAfee prompted Edwards to stop racing altogether, he sold the car to his engineer Bob Whitmer, who replaced its engine with a Chevy V8 and continued to successfully race it through the early 1960s.
The car spent most of the ensuing 50 years disassembled, though its chassis, body, engine, and gearbox were all carefully preserved in a small San Francisco-area warehouse. In 2016, a complete restoration of the car was initiated under the direction of Bob Smith Coachworks, located in Gainesville, Texas, a process that took new owners Tom and Jill Peck of southern California over two years to complete.
The refurbishment was guided by several noted Ferrari historians: Marcel Massini of Switzerland, Alan Boe of Braselton, Georgia, David Seielstad of Hawaii, as well as past owners Sterling Edwards’ son Hammond and Bob Whitmer, both from northern California. The vintage certification team at Ferrari Classiche in Maranello, Italy, was also helpful in piecing together the early racing career of the car while campaigned by Ferrari. Bringing their combined wealth of knowledge to the project, these experts employed many of the vehicle’s preserved original documents and instruments, including the original owners’ manual, toolboxes, build sheets, and a treasure trove of original photographs of the car. Computer modelling of these photos was employed to repair flaws in the body from the car’s racing days, and 3-D printing technology was utilised to duplicate some parts that were irreparable. The vehicle’s livery was restored to that which it sported in its first Carrera Panamericana race in 1954.
Once fully restored, the 1954 Ferrari 750 Monza won the Enzo Ferrari Award at the 2019 Pebble Beach Concours d’Elegance and 2020 Best of Show at the Cavallino Classic, before being named winner of The Peninsula Classics 2020 Best of the Best Award.
“It is a true honour to be recognised by the venerable judges of The Peninsula Classics,” said Mr. Peck of his car’s latest success. “Like so many classic cars, this one has been both a labour of love and the product of dedicated teamwork. The Best of the Best Award is a crowning achievement for everyone involved.”
About The Peninsula Classics Best of the Best Award
Through a shared desire to celebrate the best of what defines the automotive world, The Hon. Sir Michael Kadoorie, Chairman of The Hongkong and Shanghai Hotels, Limited, launched The Peninsula Classics Best of the Best Award in 2015 with co-founders William E. (Chip) Connor, Bruce Meyer and Christian Philippsen. Each founder shares a common passion and appreciation of fine motor cars, the preservation of their heritage and immaculate restoration projects. The award, sponsored by The Peninsula Hotels , brings together elite ‘Best of Show’ winners from nine of the renown concours circuits around the globe: Amelia Island Concours d’Elegance, Cavallino Classic, Chantilly Arts & Elegance Richard Mille, Concorso d’Eleganza Villa d’Este, Concours of Elegance Hampton Court Palace, Goodwood Cartier Style et Luxe Concours d’Elegance, Pebble Beach Concours d’Elegance, Salon Privé, and The Quail, A Motorsports Gathering.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210208005295/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces Positive CHMP Opinion for Opzelura® (ruxolitinib) Cream for the Treatment of Adults with Moderate Atopic Dermatitis26.6.2026 13:30:00 CEST | Press release
If approved, Opzelura® (ruxolitinib) cream will be the first steroid-free, topical JAK treatment option in the European Union (EU) for adults with moderate atopic dermatitis (AD) for whom standard topical therapies have failedAD, the most common type of eczema which affects 230 million people globally,1 is a chronic, recurring, inflammatory and highly pruritic (itchy) skin condition that can have a significant impact on daily life2Phase 3 TRuE‑AD4 data supporting the positive CHMP opinion demonstrated that ruxolitinib cream met both co‑primary endpoints at Week 8, maintained disease control with as-needed treatment through Week 24 and was well tolerated3,4,5 Incyte (Nasdaq: INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Opzelura® (ruxolitinib) cream for the treatment of moderate atopic dermatitis (AD) in adult patients for whom topical corticosteroids
Datroway® Recommended for Approval in the EU by CHMP as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who Are Not Candidates for Immunotherapy26.6.2026 13:00:00 CEST | Press release
Recommendation based on TROPION-Breast02 phase 3 trial where Daiichi Sankyo and AstraZeneca’s Datroway showed a statistically significant and clinically meaningful improvement for the dual primary endpoints of overall survival and progression-free survival If approved, Datroway has potential to be the first TROP2 directed antibody drug conjugate for patients in EU with a demonstrated overall survival benefit as first-line treatment Datroway® (datopotamab deruxtecan) has been recommended for approval in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use
DAYBU®(trofinetide) Recommended for Approval in the European Union by CHMP26.6.2026 12:49:00 CEST | Press release
-- European Commission decision expected in the coming months-- If approved, DAYBU®would become the first treatment for neurobehavioral symptoms of Rett syndrome in the European Union Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion following a re-examination procedure, recommending the granting of a marketing authorization for DAYBU® (trofinetide) for the treatment of neurobehavioral symptoms of Rett syndrome in adults and pediatric patients aged five years and older. If granted marketing authorization by the European Commission, DAYBU® would be the first therapy approved for this indication in the European Union (EU). “The CHMP’s positive opinion for DAYBU® is an important milestone in our mission to bring this innovative therapy to the EU, where there are no therapies specifically approved for the neurobehavioral symptoms of this devastating
HTEC Showcases Lakebase Branching at Databricks’ Data & AI Summit26.6.2026 11:18:00 CEST | Press release
HTEC, the global technology and AI engineering firm headquartered in Silicon Valley, last week showcased how it used Lakebase data branching to enable faster development, safer operations, and new possibilities for data-driven organizations operating in highly regulated environments. The Solution was developed in collaboration with a leading risk and compliance technology provider who serves financial institutions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260626875859/en/ HTEC, the global technology and AI engineering firm headquartered in Silicon Valley, last week showcased how it used Lakebase data branching to enable faster development, safer operations, and new possibilities for data-driven organizations operating in highly regulated environments. Solving Critical Development Bottlenecks in Regulated Environments At the core of the collaboration was a shared challenge: how to enable modern data workflows in an envi
Stallergenes Greer Named One of Switzerland’s Best Managed Companies for 202626.6.2026 10:28:00 CEST | Press release
Stallergenes Greer, a global leader in allergy care, has been recognised for its overall business performance, company culture, and sustained growth by receiving the prestigious 2026 Switzerland’s Best Managed Companies award. The 2026 Best Managed Companies programme award winners are among Switzerland’s best private companies. The awards are derived from Deloitte’s global Best Managed Companies awards programme, an internationally recognised programme that evaluates businesses based on their leadership in the areas of strategy, culture and commitment, capabilities, innovation, governance and financial performance. Applicants are evaluated by an independent jury of experts. The evaluation of the Switzerland awards is based on more than 30 years of observed practice from the global awards programme that has been rolled out in 50+ countries worldwide. This recognition reflects Stallergenes Greer's consistent ability to deliver on its strategic vision while maintaining the operational di
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
